BioXcel Therapeutics, Inc. (BTAIQ)
1 Item 5.02 filing since 2026-10-30 · 1 with an open seat · roles: CFO. OTC. Pharmaceutical Preparations. State: CT.
| Score | Filed | Event | Role | Person | Seat | Summary |
|---|---|---|---|---|---|---|
| 70 | 2026-10-30 | Departure | CFO | subscribers | Open | BioXcel Therapeutics, Inc. (BTAIQ): CFO Richard Steinhart terminated without cause |
Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works